The reasons South Africa’s COVID‑19 vaccine programme looks bleak
At the current vaccination pace it will take over a decade for South Africa to reach herd immunity, with many lives lost along the way.
Primary Results
COVID‑19: key questions about South Africa’s vaccine rollout plan
South Africa is aiming for 67% coverage, which translates to about 40 million people by the end of 2021.
COVID‑19: unpacking South Africa’s plan to vaccinate adolescents
Countries like the United States, Denmark, Germany, Spain and Switzerland have already vaccinated many millions of adolescents and their experience will guide countries that follow suit.
How social security could make life better in South Africa after COVID‑19
Emergency relief measures were operational for six months and are due to end soon. But the impacts of COVID-19 will be felt long after.
Antibody tests aren’t a COVID‑19 panacea. But they’re a useful additional tool
COVID-19 antibody tests can’t replace the use of PCR tests in people showing symptoms. But they can help test people who may be infected and asymptomatic.
COVID‑19 affects men and women differently. It’s important to track the data
The availability of data by sex and gender is important for national responses when it comes to prevention, treatment and control.
COVID‑19: how the lockdown has affected the health of the poor in South Africa
Poor populations bore a disproportionately higher burden of poor health.
South Africa needs a plan to protect children’s health beyond COVID‑19
Children have made many sacrifices because of the country’s COVID-19 response, including social isolation, lack of education opportunities and reduced access to nutrition programmes.
TRIPS waiver: US support is a major step but no guarantee of COVID‑19 vaccine equity
Much remains to be resolved before the waiver is translated into increased vaccine supply.
Kenya can’t afford to neglect people with underlying conditions during COVID‑19
As COVID-19 cases continue to increase in Kenya, there is a looming threat for escalated disease and death due to the many people with chronic conditions.
Secondary Results
